RxDoctor Payments Data

Jonathan Garfin

Psychiatric/Mental Health · Greenville, NCNPI 1386335826

Payments from drug & device makers

$4,250in general payments, 2019–2025

Across 173 payments — averaging $24.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$986
  • Johnson & Johnson$972
  • Vanda Pharmaceuticals Inc.$419
  • Neurocrine Biosciences, Inc.$397
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$345
  • Axsome Therapeutics, Inc.$300
  • plus $832 from 11 others

What the payments were for

  • Travel & lodging$3478%
  • Food & beverage$3,87691%
  • Education$271%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,250 in reported general payments places this provider in the 85th percentile of 947 psychiatric/mental health providers in North Carolina.

See all psychiatric/mental health providers in North Carolina

Most prescribed under Part D

DrugClaimsCost to plans & patients
SpravatoEsketamine Hcl28$57,824
NuplazidPimavanserin Tartrate12$48,356
VraylarCariprazine Hcl25$44,263
RexultiBrexpiprazole13$32,882
NuedextaDextromethorphan Hbr/Quinidine12$21,470
TrintellixVortioxetine Hydrobromide14$6,687
VyvanseLisdexamfetamine Dimesylate12$4,676
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine75$2,910
Desvenlafaxine Succinate ErDesvenlafaxine Succinate77$2,207
Venlafaxine Hcl ErVenlafaxine Hcl44$1,435
Clonazepam184$1,399
Trazodone Hcl126$1,337
Bupropion XlBupropion Hcl79$1,285
Sertraline Hcl57$819
Duloxetine Hcl86$778

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonSpravato$972$57,82428 claims
AbbVieVraylar$986$44,26325 claims
Otsuka America Pharmaceutical, Inc.Rexulti$210$32,88213 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 947 psychiatric/mental health providers in North Carolina.

Other psychiatric/mental health in Greenville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →